Maruyama vaccine contact in Tokyo.

[Guest guest]

Hello Ron, and others who are interested in the Maruyama vaccine.

I have attached contact information for getting the Maruyama vaccine

from the Nippon Medical Hospital in Tokyo. When you call the

hospital the operator will answer in Japanese and just say, " Maruyama

vaccine kudasai or Iida sensei kudasai " . I am living and working in

Japan so if you have difficulty let me know and I can help out. Also

faxing is a good way to contact him at the number listed below. I

will call him later this week to find out if he can be contacted by

email.

All the best.

Here is one part of an abstract from a paper titled " Pathological

Observations during Treatment with the Biological Response Modifier

ama Vaccine in Cancer: Implications for Collagen Production in

the Preventions of Cancer Invasion and Metastasis " . by Tetsuo

Kimoto, M.C., Ph.D. published in Cancer Detection and Prevention

(1998).

" After treatment with SSM (Maruyama Vaccine), patients and

experimental animals bearing tumors remained alive with tumors long

term. We conclude from these results that SSM acts by inducing

encapsulation of tumor growths, possibly preventing their spread and

metastasis, and that SSM may benefit patient in whom tumor is

inoprable and resistant to conventional chemotherapy. "

Please let me know if you need more information on the Maruyama

Vaccine. I will be

glad to forward it on.

If you are interested in getting the Maruyama vaccine for your friend

or anyone else that has cancer you need to fax or call Dr. Iida at

the Nippon University Hospital in Tokyo. His fax number is 813-3824-

6400 and phone number is 813-3822-2131. I just spoke with him on the

phone and the procedure is to get the patients attending doctor to

write and fax a letter supporting the use of the Maruyama vaccine (I

can fax or email you an abstract of the vaccine's effectiveness -

from an independant scientific study -if the doctor is unaware of the

vaccine.). Once the letter is received the patient has to send a

bank draft or bank cheque to the hospital for 30,000 yen about $360

CDN. This is enough vaccine for 80 days. The cost also covers the

air mail shipping charge.

>

> [ ] a vaccine that prevents metastasis.

>

>

> > Konnichiwa!! I have posted this a few months ago and will post it

> > again. I think that anyone who has cancer should seriously

consider

> > this vaccine as part of their treatment plan.

> >

> > Thousands of Japanese use this vaccine to control their cancer.

It

> > is available from the Nippon Medical University Hospital in Tokyo.

> > Email me if you want their contact information. The cost is about

> > $150 per 45 days.

> >

> > Pathological observations during treatment with the biological

> > response modifier Maruyama vaccine in cancer: implications for

> > collagen production in the prevention of cancer invasion and

> > metastasis.

> >

> > Kimoto T.

> >

> > Fujisaki Institute, Hayashibara Biochemical Laboratories

> > Incorporated, Okayama, Japan.

> >

> > The antitumor effects of Maruyama vaccine (SSM) include the

> > activation of immunocompetent cells and promotion of collagen

> > production in tumors, thereby acting as a biological response

> > modifier (BRM). On the basis of clinical observations of patients

> > responding to treatment with SSM long term, experiments in vitro

and

> > in vivo have been conducted to define the mechanisms of action of

> > SSM, and the results indicate that SSM does not exhibit direct

> > cytotoxic effects on cancer cells, but that it accelerates a

marked

> > production of collagen fibers and acts as a BRM. Proliferating

> > collagen fibers consist of type IV collagen inside tumor tissues,

and

> > types I and III collagens and fibronectin around tumor tissues

> > encapsulating tumors and their metastasis, and possibly inducing

> > necrosis in certain malignancies. These dense collagen fibers

arise

> > from the stroma, cancer cells themselves, and extracellular

matrices

> > confined within the cancerous lesion. After treatment with SSM,

> > patients and experimental animals bearing tumors remained alive

with

> > tumors long term. We conclude from these results that SSM acts by

> > inducing encapsulation of tumor growths, possibly preventing their

> > spread and metastasis, and that SSM may benefit patients in whom

> > tumor is inoperable and resistant to conventional chemotherapy.

> >

> > PMID: 9674877 [PubMed - indexed for MEDLINE]

> >

> > Be well.

> >

> >

> >

> > Learn more about cancer:

> > http://home.online.no/~dusan/diseases/cancer/

> > http://home.online.no/~dusan/diseases/cancer/faq.htm

> > http://www.geocities.com/~mycleanse/

> > http://www.geocities.com/HotSprings/1158

> >

> > You are receiving this email because you elected to subscribe to

the

> egroups